Jul 21, 2021
Clinical Trial: Does Plasma Dilution Delay Aging? | Lifespan News Extra
Posted by Montie Adkins in categories: biotech/medical, life extension, media & arts
The human trial of plasma dilution started in Russia last week. The lead researcher is checking how the biomarkers of aging will change in response to 110% plasma replacement during the therapy, and the difference between the group with albumin addition and without albumin. The trial is open to both Russian citizens and people from other countries. It is a hybrid model where part of the expenditures is paid by the volunteers, and part is provided by the patron of the research. This model allowed to get the trial started in record time — less than 9 months from conception to the start date.
The research group wants to test plasmapheresis in combination with other longevity therapies next to see if plasma dilution prior to the other therapy can enhance the results.
Continue reading “Clinical Trial: Does Plasma Dilution Delay Aging? | Lifespan News Extra” »